BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11478399)

  • 21. Recombinant AAV vector encoding human VEGF165 enhances wound healing.
    Deodato B; Arsic N; Zentilin L; Galeano M; Santoro D; Torre V; Altavilla D; Valdembri D; Bussolino F; Squadrito F; Giacca M
    Gene Ther; 2002 Jun; 9(12):777-85. PubMed ID: 12040459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
    Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
    Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
    Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF.
    Im SA; Kim JS; Gomez-Manzano C; Fueyo J; Liu TJ; Cho MS; Seong CM; Lee SN; Hong YK; Yung WK
    Br J Cancer; 2001 May; 84(9):1252-7. PubMed ID: 11336478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
    Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cloning of expression vector for VEGF121 and VEGF165 genes encoding human vascular endothelial growth factor].
    Zhou ZJ; Liu YL; Wu PS; Li XW; Zha DG; Zhou Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):111-3. PubMed ID: 12390800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of focal angiogenesis through adenoviral vector mediated vascular endothelial cell growth factor gene transfer in the mature mouse brain.
    Yang GY; Xu B; Hashimoto T; Huey M; Chaly T; Wen R; Young WL
    Angiogenesis; 2003; 6(2):151-8. PubMed ID: 14739621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.
    Akita S; Daian T; Ishihara H; Fujii T; Akino K
    J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells].
    Yan R; Xin X; Jin M; Hui H; Wang J; Wang D
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):683-6. PubMed ID: 12487926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The in vivo and in vitro effects on neovascularization of VEGF gene transfer with a new pseudotyped rAAV1 vector].
    Yan H; Wu XB; Guo YH; Zhang P; Chen L; Dong XY; Wang GS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):69-73. PubMed ID: 17386170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applications of angiogenic growth factors and their inhibitors.
    Ferrara N; Alitalo K
    Nat Med; 1999 Dec; 5(12):1359-64. PubMed ID: 10581076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases.
    Lee Y; Park EJ; Yu SS; Kim DK; Kim S
    Biochem Biophys Res Commun; 2000 May; 272(1):230-5. PubMed ID: 10872832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo.
    Mühlhauser J; Merrill MJ; Pili R; Maeda H; Bacic M; Bewig B; Passaniti A; Edwards NA; Crystal RG; Capogrossi MC
    Circ Res; 1995 Dec; 77(6):1077-86. PubMed ID: 7586219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.